We've got you covered
We are here to guide you in making tough decisions with your hard earned money. Drop us your details and we will reach you for a free one on one discussion with our experts.
or
Call us on: +917410000494
Caplin Point Laboratories Limited develops, produces, markets, and exports generic pharmaceutical formulations and branded products in India. The company provides liquid and lyophilized injections, ophthalmic products, tablets, liquid orals, capsules, softgel capsules, suppositories and ovules, powder for injection, dry syrups, topicals, inhalers, IV infusions, lyophilized products, branded products, dermo cosmetics, and other products. It also operates QueTenX, an e-commerce website. The company was incorporated in 1990 and is headquartered in Chennai, India.
TODAY'S HIGH
738.75
TODAY'S LOW
706
52 WEEK HIGH
1034.8
52 WEEK LOW
626
% of Shares Held by
All Insider
74.05%
% of Shares Held by
Institutions
1.95%
% of Float Held by
Institutions
7.50%
Number of Institutions
Holding Shares
19
MARKET CAP
5570.95 Cr.
ETERPRISE VALUE
4884.65 Cr.
NO. OF SHARES
7.58 Cr.
BOOK VALUE
195.798
DIV. YIELD
2%
DEBT
2.13 Cr.
GROSS PROFIT
711.90 Cr.
CASH
514.95 Cr.
REVENUE
1269.40 Cr.
REVENUE/SHARE
167.694
| Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|
| Investments | -199.36 Cr. | 51.57 Cr. | 14.62 Cr. | -23.46 Cr. |
| Change To Liabilities | 83.77 Cr. | 26.98 Cr. | 31.24 Cr. | -28.46 Cr. |
| Total cashflows from Investing Activities | -270.94 Cr. | -5.35 Cr. | -54.50 Cr. | -100.45 Cr. |
| Net Borrowings | -16.56 Cr. | -19.41 Cr. | -21.53 Lakhs | -3.51 Lakhs |
| Total Cash from Financing Activities | -40.71 Cr. | -23.97 Cr. | 79.76 Cr. | 89.78 Cr. |
| Other Liabilities | 7.23 Cr. | -40.61 Cr. | 29.34 Cr. | -48.68 Cr. |
| Total Assets | 0 | 0 | 25 k | 54 k |
| Net Income | 299.84 Cr. | 242.26 Cr. | 215 Cr. | 176.56 Cr. |
| Change in Cash | 25.01 Cr. | 236.19 Cr. | 70.11 Cr. | 73.48 Cr. |
| Effect of Exchange Rate | -9 Lakhs | -23.82 Lakhs | 17.48 Lakhs | 72.16 Lakhs |
| Total Cash from Operating Activities | 336.75 Cr. | 265.77 Cr. | 44.67 Cr. | 83.42 Cr. |
| Depreciation | 46.90 Cr. | 35.80 Cr. | 30.86 Cr. | 23.01 Cr. |
| Other Cashflows from Investing Activities | 19.60 Cr. | 13.54 Cr. | -1.50 Cr. | -11.80 Cr. |
| Dividends Paid | -22.69 Cr. | -3.02 Cr. | -32.52 Cr. | -15.12 Cr. |
| Change to Inventory | -48.31 Cr. | 59.22 Cr. | -7.03 Cr. | -8.98 Cr. |
| Change to Account Receivables | -40.70 Cr. | -50.39 Cr. | -230.66 Cr. | -33.92 Cr. |
| Other Cashflows from Financing Activities | -1.46 Cr. | -1.54 Cr. | -49.54 Lakhs | -6 Lakhs |
| Change to Net Income | -11.98 Cr. | -8.66 Cr. | -24.83 Cr. | 3.49 Cr. |
| Capital Expenditures | -91.18 Cr. | -70.48 Cr. | -76.73 Cr. | -65.18 Cr. |
| Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|
| Research Development | 0 | 53.69 Cr. | 53.01 Cr. | 28.18 Cr. |
| Effect of Accounting Charges | None | None | None | None |
| Income Before Tax | 385.82 Cr. | 313.61 Cr. | 269.46 Cr. | 226.87 Cr. |
| Minority Interest | 25.95 Cr. | 17.53 Cr. | 8.65 Cr. | 7.88 Lakhs |
| Net Income | 347.77 Cr. | 293.32 Cr. | 229.24 Cr. | 208.22 Cr. |
| Selling General Administrative | 115.30 Cr. | 102.61 Cr. | 67.77 Cr. | 47.10 Cr. |
| Gross Profit | 711.90 Cr. | 581.72 Cr. | 443.42 Cr. | 351.43 Cr. |
| Ebit | 347.77 Cr. | 293.32 Cr. | 229.24 Cr. | 208.22 Cr. |
| Operating Income | 347.77 Cr. | 293.32 Cr. | 229.24 Cr. | 208.22 Cr. |
| Other Operating Expenses | 201.93 Cr. | 95.20 Cr. | 61.78 Cr. | 44.49 Cr. |
| Interest Expense | -70 Lakhs | -1.58 Cr. | -31.97 Lakhs | -6 Lakhs |
| Extraordinary Items | None | None | None | None |
| Non Recurring | None | None | None | None |
| Other Items | None | None | None | None |
| Income Tax Expense | 77.37 Cr. | 62.18 Cr. | 54.37 Cr. | 50.32 Cr. |
| Total Revenue | 1269.41 Cr. | 1062.35 Cr. | 863.95 Cr. | 649 Cr. |
| Total Operating Expenses | 921.64 Cr. | 769.02 Cr. | 634.71 Cr. | 440.78 Cr. |
| Cost of Revenue | 557.51 Cr. | 480.62 Cr. | 420.53 Cr. | 297.57 Cr. |
| Total Other Income Expense Net | 38.05 Cr. | 20.28 Cr. | 40.21 Cr. | 18.64 Cr. |
| Discontinued Operations | None | None | None | None |
| Net Income from Continuous Ops. | 308.45 Cr. | 251.43 Cr. | 215.08 Cr. | 176.55 Cr. |
| Net Income Applicable to Common Shares | 299.84 Cr. | 242.26 Cr. | 215 Cr. | 176.56 Cr. |
| Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|
| Intangible Assets | 10.85 Cr. | 7.23 Cr. | 5.01 Cr. | 2.10 Cr. |
| Capital Surplus | 0 | 2.12 Cr. | 2.12 Cr. | 1.62 Cr. |
| Total Liabilities | 226.44 Cr. | 160.24 Cr. | 169.18 Cr. | 109.53 Cr. |
| Stock Holder Equity | 1483.93 Cr. | 967.82 Cr. | 729.91 Cr. | 527.90 Cr. |
| Minority Interest | 25.95 Cr. | 17.53 Cr. | 8.65 Cr. | 7.88 Lakhs |
| Other Liabilities | 40.98 Cr. | 23.85 Cr. | 29.71 Cr. | 23.94 Cr. |
| Total Assets | 1736.32 Cr. | 1363.60 Cr. | 1125.75 Cr. | 742.51 Cr. |
| Common Stock | 15.16 Cr. | 15.12 Cr. | 15.12 Cr. | 15.12 Cr. |
| Retained Earnings | 0 | 925.69 Cr. | 686.45 Cr. | 503.97 Cr. |
| Other Liabilities | 17.59 Cr. | 16.86 Cr. | 23.56 Cr. | 23.13 Cr. |
| Good Will | 0 | 5.37 Lakhs | 5.37 Lakhs | 0 |
| Treasury Stock | 1468.77 Cr. | 24.87 Cr. | 26.20 Cr. | 7.17 Cr. |
| Other Assets | 97.19 Cr. | 7.91 Cr. | 10.04 Cr. | 11.95 Cr. |
| Cash | 462.99 Cr. | 231.57 Cr. | 49.92 Cr. | 49.32 Cr. |
| Current Liabilities | 207.68 Cr. | 142.85 Cr. | 144.32 Cr. | 86.11 Cr. |
| Long Term Asset Charges | 6.21 Cr. | 0 | 0 | 0 |
| Short Long Term Debt | 50 Lakhs | 17.06 Cr. | 36.46 Cr. | 25.44 Lakhs |
| Other Stockholder Equity | 1468.77 Cr. | 24.87 Cr. | 26.20 Cr. | 7.17 Cr. |
| Property Plant Equipment | 293.45 Cr. | 311.92 Cr. | 287.55 Cr. | 234.43 Cr. |
| Total Cur. Assets | 1297.82 Cr. | 1035.80 Cr. | 822.53 Cr. | 493.68 Cr. |
| Long Term Investments | 37.01 Cr. | 66.35 Lakhs | 55.54 Lakhs | 33.30 Lakhs |
| Net Tangible Assets | 1473.08 Cr. | 960.52 Cr. | 724.84 Cr. | 525.80 Cr. |
| Short Term Investments | 51.97 Cr. | 225.38 Cr. | 170.83 Cr. | 101.33 Cr. |
| Net Receivables | 424.71 Cr. | 299.60 Cr. | 243.83 Cr. | 169.02 Cr. |
| Long Term Debt | 0 | 0 | 1.52 Lakhs | 28.68 Lakhs |
| Inventory | 227.31 Cr. | 179 Cr. | 238.23 Cr. | 37.44 Cr. |
| Accounts Payable | 163.18 Cr. | 88.50 Cr. | 64.13 Cr. | 60.47 Cr. |
Open a demat account through us and get the account opening charges waived off
open paperless account